Organization: Cytochroma Inc

Cytochroma Inc raises additional $21 million in VC

Privately held Cytochroma Inc, Markham ON, has received $21 million in venture capital financing to expand the development of potential products for vitamin D deficiency and other diseases related to chronic kidney disease. The latest funding brings the total raised since 2001 to $58 million and follows last year’s acquisition of Madison WI-based Proventiv Therapeutics…

Cytochroma Inc boosts private placement by $3.5M

Two Quebec investment firms have added $3.5 million to a $12-million private equity financing of Cytochroma Inc announced late last year (R$, November 13/01). T2C2 Bio/2000 LP and CDP Sofinov have provided $2.5 million and $1 million respectively to the financing, which will expand and accelerate the R&D program of the Kingston ON-based applied genomics…

Cytochroma secures $12-million private financing

Kingston ON-based Cytochroma Inc has closed a $12-million private equity financing to advance its R&D of therapeutics based on cytochrome P450-based metabolism. The Business Development Bank of Canada’s Venture Capital Division is the lead investor, with participation from Novo A/S (Denmark), GeneChem Technologies Venture Fund LP, Canadian Medical Discoveries Fund and Working Ventures Canadian Fund…

Cytochroma and Allergan expand R&D collaboration

Cytochroma Inc, Kingston ON, has expanded its R&D collaboration with Allergan, Irvine CA to develop inhibitors of retinoic acid metabolism. The two firms have already successfully completed initial research on two cytochrome enzymes responsible for the breakdown of retinoic acid in humans. The exploration of new indicators is covered in the new agreement, which spans…

Cytochroma and Molecular Mining join forces

Kingston ON-based Cytochroma Inc is collaborating with Molecular Mining Corp (also of Kingston), to expand Cytochroma’s library of validated molecular targets for drug discovery. Molecular Mining is contributing its data mining and modelling platform to the collaboration and applying it to Cytochroma’s cytochrome P450 structure to explore the human genome….